At a recent awareness session, experts from HCG Cancer Centre, Kolkata, emphasised that early detection, genetic risk assessment, and personalised care are transforming breast cancer outcomes.
With India recording over 192,000 new cases annually (GLOBOCAN 2022), Dr. Jyoti Gupta (Consultant, Breast Surgery) urged a shift from anxiety to action. She highlighted that modern, biology-driven treatments, such as breast-conserving surgery and targeted therapies, effectively control cancer while preserving a patient’s quality of life. Furthermore, testing for BRCA1/BRCA2 mutations offers vital preventive strategies for high-risk families.
Dr. Rupali Basu (Regional Business Head) noted that localised breast cancer boasts a 99% survival rate when caught early.
Warning Signs: Women of all ages should promptly check for painless lumps, nipple discharge/retraction, skin dimpling, or persistent changes.
As a premier NABH-accredited facility, HCG Kolkata remains committed to advanced, multidisciplinary cancer care.